• Mashup Score: 5

    Current sequencing-based spatial transcriptomic methods have been widely used to resolve gene expression; however, these methods are limited to fresh or fresh-frozen samples due to the low efficiency of oligo(dT) primers in capturing RNA transcripts in degraded samples. Here, we have developed a random primer-based spatial total RNA sequencing (spRandom-seq) technology for capturing full-length total RNAs in partially degraded (low RIN values) formalin-fixed paraffin-embedded (FFPE) tissues. Our spRandom-seq approach exhibited no discernible biases at the 3’- or 5’-ends within gene bodies and could be integrated with the commercially available 10X Visium and other well-established sequencing-based spatial transcriptomic platforms. Our spRandom-seq approach outperformed oligo(dT)-based 10X Visium with an 8-fold higher capturing rate for long-non-coding RNA (lncRNA) and other non-polyadenylated RNA biotypes, including miRNA, snRNA, and miscRNA. The unsupervised clustering with solely non

    Tweet Tweets with this article
    • RT @LukasValihrach: Spatial Total RNA Sequencing of Formalin-Fixed Paraffin Embedded Tissues by spRandom-seq https://t.co/qMUGI4at5w

  • Mashup Score: 14

    Login with your AGA username and password. Section of Surgical Sciences, Vanderbilt University Medical Center, Nashville, TN, United States Epithelial Biology Center, Vanderbilt University Medical Center, Nashville, TN, United States Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan Department of Gastroenterology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan Department of Gastroenterology and Hepatology

    Tweet Tweets with this article
    • Pharmacological inhibition of the RAS pathway in PRECANCERS for cancer interception enters the clinic. In @AGA_Gastro Safety and efficacy of MEK inhibitor treatment for gastric pre-cancerous lesions (intestinal metaplasia) https://t.co/zJDpNGfH4e https://t.co/TkC3osKtzO

  • Mashup Score: 19

    Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths in the United States and compiles the most recent data on population-based cancer occurrence and outcomes u…

    Tweet Tweets with this article
    • Major challenges: - Cancer disparities remain widespread - Cancer incidence in women continues to rise surpassing men in Gen X already - Challenges of recalcitrant cancers like #PancreaticCancer persist Link to the #OpenAccess paper https://t.co/UtlS5vt3bT

  • Mashup Score: 11

    After weeks of discomfort, the 25-year-old man got a shocking explanation for his abdominal pain.

    Tweet Tweets with this article
    • 25 year old man with #PancreaticCancer arising in association with a pancreatic pseudocyst (presenting symptoms). Strange case. Cannot tell if the lesion is an adenocarcinoma or a variant histology. At 25y, I hope they looked for germline mutations. https://t.co/64dEn2R9rM

  • Mashup Score: 1

    Official websites use .gov A.gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock (🔒) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

    Tweet Tweets with this article
    • Link to new policy https://t.co/SFmwEr72Jj

  • Mashup Score: 29

    Background: The Pancreatic Cancer Action Network (PanCAN) established its Patient Registry to gather real-world data from patients with pancreatic cancer and their caregivers, related to their diagnosis, symptoms and symptom management, treatments, and more. Described here are results from version 2 of the PanCAN Registry. Objective: We sought to gather and evaluate patient-reported outcomes (PRO) data inputted into the PanCAN Patient Registry from December 2020 to January 2024. Statistical analyses were employed to identify findings from a relatively small sample size (271 participants, as defined by people who filled out the Basics survey of the PanCAN Registry). Methods: Participation in the PanCAN Patient Registry was voluntary, and participants filled out an online consent form prior to joining the registry. Participants were identified through the PanCAN Patient Services Help Line or navigated to the registry directly via the pancan.org website. Data analysis took place via bivar

    Tweet Tweets with this article
    • Understanding the Experiences of Patients With #PancreaticCancer: Quantitative Analysis of the @PanCAN Patient Registry https://t.co/tSvGWJKUGQ Almost 90% of patients report pain, 2/3rd report depression. Reiterating the importance of multidisciplinary management beyond oncology.